Re-Imbursed Pharmaceutical Market

This key economic indicator for the Pharmaceutical sector has been recently updated.

  1. Austria Re-Imbursed Pharmaceutical Market jumped by 2.8points in 2019, compared to a year earlier.
  2. Since 2014 Turkey Re-Imbursed Pharmaceutical Market grew 3.3points year on year to 36.2 Percent of Generics in Value.
  3. In 2019 United Kingdom was ranked number 2 in Re-Imbursed Pharmaceutical Market.

Top Countries in Re-Imbursed Pharmaceutical Market

# 17 Countries Percent of Generics in Value Last YoY 5‑years CAGR
1 #1
Austria
52.20 % 2019 +2.8 % +2.2 % View data
2 #2
United Kingdom
38.50 % 2019 +2.1 % +2.6 % View data
3 #3
Turkey
36.20 % 2019 -3.7 % +3.3 % View data
4 #4
New Zealand
33.10 % 2019 +1.2 % +0.7 % View data
5 #5
Germany
32.90 % 2019 +1.5 % -1.9 % View data
6 #6
Canada
26.80 % 2019 -2.9 % -4.1 % View data
7 #7
Greece
25.30 % 2019 +11.9 % +5.9 % View data
8 #8
Slovakia
25.20 % 2019 -4.2 % -7.8 % View data
9 #9
Portugal
25.00 % 2019 -1.6 % +0.7 % View data
10 #10
Spain
23.60 % 2019 +5.4 % +1.6 % View data
11 #11
Denmark
21.50 % 2019 +14.4 % +6.9 % View data
12 #12
Switzerland
20.40 % 2019 +1.5 % +1.5 % View data
13 #13
Netherlands
19.70 % 2019 -1.5 % +3.6 % View data
14 #14
Ireland
15.50 % 2019 +4.0 % -1.1 % View data
15 #15
Belgium
13.90 % 2019 +4.5 % +0.9 % View data
16 #16
Italy
9.40 % 2019 +1.1 % +1.6 % View data
17 #17
Luxembourg
5.80 % 2019 +0.0 % +4.3 % View data

Source: OECD

Go Top